REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Uc Biosciences, Inc. (Philippines)

Main Activities: Other Miscellaneous Nondurable Goods Merchant Wholesalers
Full name: Uc Biosciences, Inc. Profile Updated: December 19, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

The subject is engaged in the import and trading of various medical devices and equipment to hospitals, clinics and other health care facilities in accordance with law, on wholesale basis.

Headquarters
Unit 905-906 The Orient Square Condominium, Don F. Ortigas Jr. Road, Ortigas Center, San Antonio
Pasig City;

Contact Details: Purchase the Uc Biosciences, Inc. report to view the information.

Basic Information
Financial Auditors:
Purchase the Uc Biosciences, Inc. report to view the information.
Incorporation Date:
March 30, 2016
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
30%
Purchase this report to view the information.
30%
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Uc Biosciences, Inc. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PHP. Absolute financial data is included in the purchased report.
Net sales revenue
15.15%▲
Total operating revenue
15.15%▲
Operating Profit/Loss (EBIT)
45.01%▲
EBITDA
40.87%▲
Net Profit/Loss for the Period
45.77%▲
Total Assets
-12.8%▼
Total Equity
-32.33%▼
Operating Profit Margin (ROS)
2.02%▲
Net Profit Margin
2.62%▲
Return on Equity (ROE)
17.86%▲
Quick Ratio
-0.63%▼
Cash Ratio
0.03%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo